Health and Healthcare
5864 Articles
Cell Genesys, Inc. (NASDAQ: CEGE) plans to offer 7.1 million shares of common stock and warrants at an equivalent of…
Who thought generics could ever look so bad? This morning, Barr Pharmaceuticals (NYSE: BRL) has posted very poor numbers. The…
REGENERX BIOPHARMACEUTICALS, INC. (AMEX: RGN) filed for a secondary offering late yesterday to sell some $60 million in a secondary…
Here are some of the top stories today that affecting key drug and biotech stocks: GlaxoSmithKline (NYSE: GSK) reorganized its…
WuXi PharmaTech (Cayman) Inc. (NYSE: WX) announced today that it has decided to postpone its follow-on offering of American Depository…
Big Pharma continues to throw ballast out of the balloon in the hopes of staying aloft. The latest victim of…
Cougar Biotechnology, Inc. (NASDAQ: CGRB) is up over 5% in afternoon trading on the announcement that they will present a…
There are lots of names moving in biotech and related fields today, and below are some of the top movers:…
Generex Biotechnology Company (NASDAQ: GNBT), a drugdelivery system and technology developer, has filed an offering by sellingstockholders of up to…
Sun Healthcare Group (NASDAQ: SUNH) has filed for a mixed shelfoffering of $200 million this morning. They may periodically offer…
Today almost feels like the "March of Biotech-inguins" because most of the movers were small companies you might otherwise miss. …
Genentech, Inc. (NYSE:DNA) and Biogen Idec, Inc. (Nasdaq:BIIB) came out this morning with some disappointing news. The biotech giants have…
Merck (MRK) had high hopes for its cholesterol drug Cordaptive According to The Wall Street Journal, things did not work…
Pharmacy benefits managers Express Scripts Inc. (NASDAQ: ESRX) and MedcoHealth Solutions Inc. (NASDAQ: MHS) are both set to report earnings…
Bristol-Myers Squibb (NYSE: BMY) has submitted an open shelf offering today for an undetermined amount. The offering includes a combination…
Our top personal finance-related articles today. Your wallet will thank you later.